To evaluate the potential influence of NTZ on LAM disease, preliminary experiments using mouse embryonic fibroblasts and the LAM-related angiomyolipoma cell line 621-101 were performed, with the read-out being S6 phosphorylation as a stand-in for mTORC1 activity. Here, RPS6 is linked to lymphangioleiomyomatosis.